Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (241-250 of 329) with videos related to

Pageof 33
Sort By:
Respiratory Research|April 27, 2018
Rituximab for auto-immune alveolar proteinosis, a real life cohort studyBerenice Soyez, Raphael Borie, Cedric Menard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2021
Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLCMarius Ilié, Julien Mazières, Emmanuel Chamorey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring <i>HER2</i> Mutations: Results From the IFCT-1703 R2D2 TrialJulien Mazieres, Claire Lafitte, Charles Ricordel, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2023
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)Agathe Dehem, Julien Mazieres, Ali Chour, et al.
Plos One|August 14, 2013
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian populationRaphael Borie, Bruno Crestani, Philippe Dieude, et al.
The European Respiratory Journal|October 26, 2019
Computed tomography assessment of peripheral traction bronchiolectasis: impact of minimal intensity projectionConstance de Margerie-Mellon, Lisa Belin, Samia Boussouar, et al.
BMJ Open Respiratory Research|June 5, 2021
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundanceMuriel Fartoukh, Alexandre Demoule, Olivier Sanchez, et al.
JAMA Network Open|April 17, 2024
Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and NewbornsPaul Gougis, Anne-Sophie Hamy, Floriane Jochum, et al.
The European Respiratory Journal|February 17, 2018
Safety and efficacy of pirfenidone in patients carrying telomerase complex mutationAurélien Justet, Gabriel Thabut, Effrosyni Manali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTEMarie Wislez, Fabrice Barlesi, Benjamin Besse, et al.
Pageof 33

Showing results (241-250 of 329) with videos related to

Sort By:
Pageof 33
Respiratory Research|April 27, 2018
Rituximab for auto-immune alveolar proteinosis, a real life cohort studyBerenice Soyez, Raphael Borie, Cedric Menard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2021
Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLCMarius Ilié, Julien Mazières, Emmanuel Chamorey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring <i>HER2</i> Mutations: Results From the IFCT-1703 R2D2 TrialJulien Mazieres, Claire Lafitte, Charles Ricordel, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2023
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)Agathe Dehem, Julien Mazieres, Ali Chour, et al.
Plos One|August 14, 2013
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian populationRaphael Borie, Bruno Crestani, Philippe Dieude, et al.
The European Respiratory Journal|October 26, 2019
Computed tomography assessment of peripheral traction bronchiolectasis: impact of minimal intensity projectionConstance de Margerie-Mellon, Lisa Belin, Samia Boussouar, et al.
BMJ Open Respiratory Research|June 5, 2021
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundanceMuriel Fartoukh, Alexandre Demoule, Olivier Sanchez, et al.
JAMA Network Open|April 17, 2024
Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and NewbornsPaul Gougis, Anne-Sophie Hamy, Floriane Jochum, et al.
The European Respiratory Journal|February 17, 2018
Safety and efficacy of pirfenidone in patients carrying telomerase complex mutationAurélien Justet, Gabriel Thabut, Effrosyni Manali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTEMarie Wislez, Fabrice Barlesi, Benjamin Besse, et al.
Pageof 33